GlassScriptPhysician profile
Stephanie Lf Gustin
NPI 1013243740
$1,679.91
in general payments reported to CMS, 2019-2025
19 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $79.56 · 2021: $218 · 2022: $210 · 2023: $289 · 2024: $331 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $347.23 | 2019-2025 | Menopur |
| Emd Serono, INC. | $326.40 | 2019-2025 | |
| Coopersurgical, INC. | $271.33 | 2024-2025 | Stripper, Origio Sequential Fert |
| Abbvie INC. | $141.30 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $136.40 | 2023-2025 | Myfembree |
| Organon LLC | $72.80 | 2021-2024 | Follistim Aq |
| Meditrina | $61.96 | 2021-2022 | |
| Hologic Sales and Service, LLC | $55.24 | 2024-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Merck Sharp & Dohme LLC | $48.24 | 2019-2020 | |
| Myovant Sciences INC. | $44.95 | 2021-2022 | |
| Baxter Healthcare | $41.93 | 2022 | |
| Tersera Therapeutics LLC | $24.79 | 2023 | Zoladex |
| Covidien LP | $23.31 | 2019 | |
| Virtus Pharmaceuticals LLC | $17.58 | 2021 | |
| Galen US INC | $16.10 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.31 | 2023 | |
| Agiliti Surgical, INC. | $13.19 | 2019 | |
| Boston Scientific Corporation | $11.56 | 2019 | |
| Novo Nordisk INC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Gustin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.